ArticleFuture oncology (London, England)2025

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.

Philipp Ivanyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.